evt | Article | February 2017
evt | Article | September 2009
Current Perspective on Self-Expanding Stents for Acute Ischemic Stroke
Experience with this technique and a preview of the first FDA-approved prospective trial, SARIS.
By Elad I. Levy, MD, FACS, FAHA; Sabareesh K. Natarajan, MD, MS; Adnan H. Siddiqui, MD, PhD; Kenneth V. Snyder, MD, PhD; Erik F. Hauck, MD, PhD; J Mocco, MD, MS; and L. Nelson Hopkins, MD, FACS
evt | Article | August 2020
evt | Article | February 2018
evt | News | April 14, 2014
Reverse Medical to Study Barrel VRD to Treat Intracranial Bifurcation Aneurysms
April 15, 2014—Reverse Medical Corporation (Irvine, CA) announced that the US Food and Drug Administration approved an investigational device exemption for a clinical study of the company’s Barrel vascular reconstruction device (VRD).
evt | News | July 25, 2011
Penumbra Initiates THERAPY Trial for Treatment of Acute Ischemic Stroke
July 26, 2011—Penumbra, Inc. (Alameda, CA) announced immediate commencement of the THERAPY (The Randomized, Concurrent Controlled Trial to Assess the Penumbra System's Safety and Effectiveness in the Treatment of Acute Stroke) trial at the Society of NeuroInterventional Surgery 8th Annual Meeting in Colorado Springs, Colorado.
evt | News | July 31, 2014
Written Emergency Stroke Care Protocols Shown to Improve Hospital Performance
August 1, 2014—The Society of NeuroInterventional Surgery (SNIS) announced that new data presented at the SNIS 11th annual meeting in Colorado Springs, Colorado, demonstrated that written care protocols can significantly improve the overall emergency care pathway for stroke.
evt | Article | July 2020
Stroke Care Trends During the COVID-19 Pandemic
Three neurointerventionalists share their experiences treating stroke amidst the pandemic, thoughts on why some institutions are seeing a lower incidence of stroke, and a look at the Society for NeuroInterventional Surgery’s public awareness initiative.
With Dorothea Altschul, MD, FAHA; Richard P. Klucznik, MD; and James Milburn, MD, FACR
evt | Article | August 2010
evt | News | September 16, 2012
Registry Supports Codman Enterprise System to Treat Cerebral Aneurysms
September 17, 2012—Codman Neurovascular, Inc., a unit of Codman & Shurtleff, Inc. (Raynham, MA) announced that 21-month data from a registry evaluating the Codman Enterprise vascular reconstruction device (VRD) and delivery system were published by Karl M. Fargen, MD, et al in Neurosurgery.
evt | Article | February 2017
evt | News | January 24, 2018
COMPASS Compares Penumbra's Aspiration System to Stent Retrievers in Acute Ischemic Stroke
January 25, 2018—Penumbra, Inc. announced the presentation of results from the COMPASS trial, showing that the use of Penumbra's aspiration system was noninferior to stent retrievers for patients with acute ischemic stroke.
evt | News | February 23, 2016
SEER Meta-Analysis Supports Medtronic's Solitaire Stent Retriever For Acute Ischemic Stroke Treatment
February 23, 2016—Medtronic plc announced that results from the Safety and Efficacy of Solitaire Stent Thrombectomy (SEER)—Individual Patient Data Meta-Analysis of Randomized Trials were presented at the International Stroke Conference, which was held February 17 to 19 in Los Angeles, California.